LIAISON XL MUREX Control HIV Ab/Ag HT

GUDID 18056771500231

DIASORIN S.P.A.

HIV1/HIV2 antigen/antibody IVD, control

• Primary Device ID: 18056771500231
• NIH Device Record Key: 1d41c837-d8c0-4134-a3b5-d517e5aab072
• Commercial Distribution Status: In Commercial Distribution
• Brand Name: LIAISON XL MUREX Control HIV Ab/Ag HT
• Version Model Number: 318291
• Company DUNS: 216357118
• Company Name: DIASORIN S.P.A.
• Device Count: 1
• DM Exempt: false
• Pre-market Exempt: false
• MRI Safety Status: Labeling does not contain MRI Safety Information
• Human Cell/Tissue Product: false
• Device Kit: true
• Device Combination Product: false
• Single Use: true
• Lot Batch: true
• Serial Number: false
• Manufacturing Date: false
• Expiration Date: true
• Donation Id Number: false
• Contains Natural Rubber Latex: false
• Labeled No Natural Rubber Latex: false
• RX Perscription: true
• OTC Over-The-Counter: false

Device Identifiers

Device Issuing Agency	Device ID
GS1	08056771500234 [Primary]
GS1	18056771500231 [Package]; Contains: 08056771500234; Package: [10 Units]; In Commercial Distribution

Sterilization

• Steralize Prior To Use: false
• Device Is Sterile: false

Device Entry Metadata

• Public Version Status: New
• Device Record Status: Published
• Public Version Number: 1
• Public Version Date: 2021-05-12
• Device Publish Date: 2021-05-04

Devices Manufactured by DIASORIN S.P.A.

• 18056771500200 - LIAISON XL MUREX HIV Ab/Ag HT: 2021-05-12
• 18056771500231 - LIAISON XL MUREX Control HIV Ab/Ag HT: 2021-05-12
• 18056771500231 - LIAISON XL MUREX Control HIV Ab/Ag HT: 2021-05-12
• 28056771103583 - LIAISON XL MUREX HBsAg Confirmatory: 2021-04-21
• 18056771500187 - LIAISON XL MUREX HBsAg Qual: 2021-04-21
• 28056771500214 - LIAISON XL MUREX Control HBsAg Qual: 2021-04-21
• 08056771500197 - LIAISON® XL MUREX HCV Ab: 2020-03-04
• 08056771500227 - LIAISON® XL MUREX Control HCV Ab: 2020-03-04